Search results for " s.p.a."

showing 10 items of 253 documents

Luminescent supramolecular heterometallic macrocycles and their encapsulation on cholate gels

2018

The metal complex formed by coordination of Zn(II) to 1,7-bis(4-methylpyridine)-4-(2- naphthylmethyl)-1,4,7-triazaheptane (ZnL2+) was reacted in aqueous solution with [Pd(NO3)2(en)] and [Pt(NO3)2(en)] salts to form the self-assembled heterometallic macrocycles [Zn2L2Pd2(en)2]8+ and [Zn2L2Pt2(en)2]8+, respectively. Pd(II) and Pt(II)- coordination modulates the original emission of ZnL2+ arising from the presence of the naphthalene chromophore and the formation of the macrocycles can be monitored due to the PET process occurring with coordination of Pd(II) and Pt(II) to the pyridine units of ZnL2+. Additionally, several studies reveal that these heteromacrocycles can be encapsulated in Zn(II)…

LuminescenceGels (Farmàcia)ChemistrySupramolecular chemistryLuminescència02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesQuímica supramolecular0104 chemical sciencesEncapsulation (networking)Inorganic ChemistryChemical engineeringSelf-assembly0210 nano-technologyLuminescenceSupramolecular chemistryGels (Pharmacy)
researchProduct

Coordination networks incorporating halogen-bond donor sites and azobenzene groups

2016

Two Zn coordination networks, {[Zn(1)(Py)2]2(2-propanol)}n (3) and {[Zn(1)2(Bipy)2](DMF)2}n (4), incorporating halogen-bond (XB) donor sites and azobenzene groups have been synthesized and fully characterized. Obtaining 3 and 4 confirms that it is possible to use a ligand wherein its coordination bond acceptor sites and XB donor sites are on the same molecular scaffold (i.e., an aromatic ring) without interfering with each other. We demonstrate that XBs play a fundamental role in the architectures and properties of the obtained coordination networks. In 3, XBs promote the formation of 2D supramolecular layers, which, by overlapping each other, allow the incorporation of 2-propanol as a gues…

MOF Supramolecular Chemistry Halogen Bonding AzobenzeneStereochemistry116 Chemical sciencesSupramolecular chemistry02 engineering and technology010402 general chemistryRing (chemistry)01 natural sciencesIUPAC RECOMMENDATIONS 2013chemistry.chemical_compoundMETAL-ORGANIC FRAMEWORKSdell'Università e della RicercaCHEMISTRYTO-CRYSTAL ISOMERIZATIONMinistero dell'IstruzioneMoleculeGeneral Materials Scienceta215SUPRAMOLECULAR SYNTHESISHalogen bondMETAL-ORGANIC FRAMEWORKS; IUPAC RECOMMENDATIONS 2013; TO-CRYSTAL ISOMERIZATION; SUPRAMOLECULAR SYNTHESIS; VISIBLE-LIGHT; POLYMERS; FLUOROAZOBENZENES; COCRYSTALS; COMPLEXES; CHEMISTRYLigandChemistryFLUOROAZOBENZENESMinistero dell'Istruzione dell'Università e della RicercaGeneral ChemistryCOCRYSTALS021001 nanoscience & nanotechnologyCondensed Matter PhysicsAcceptor0104 chemical sciencesCrystallographyAzobenzeneMIURMetal-organic frameworkCOMPLEXESSettore CHIM/07 - Fondamenti Chimici Delle TecnologieVISIBLE-LIGHTPOLYMERS0210 nano-technology
researchProduct

European Clinical Experience with a Dual Chamber Single Pass Sensing and Pacing Defibrillation Lead

2002

Dual chamber ICDs are increasingly implanted nowadays, mainly to improve discrimination between supraventricular and ventricular arrhythmias but also to maintain AV synchrony in patients with bradycardia. The aim of this study was to investigate a new single pass right ventricular defibrillation lead capable of true bipolar sensing and pacing in the right atrium and integrated bipolar sensing and pacing in the right ventricle. The performance of the lead was evaluated in 57 patients (age 61 +/- 12 years; New York Heart Association 1.9 +/- 0.6, left ventricular ejection fraction 0.38 +/- 0.15) at implant, at prehospital discharge, and during a 1-year follow-up. Sensing and pacing behavior of…

MaleBradycardiaTachycardiaPacemaker Artificialmedicine.medical_specialtyDefibrillationHeart Ventriclesmedicine.medical_treatmentImplantable defibrillatorElectrocardiographyInternal medicineTachycardia SupraventricularmedicineHumansHeart AtriaProspective Studiescardiovascular diseasesLead (electronics)AgedEjection fractionbusiness.industryP waveGeneral MedicineMiddle AgedDefibrillators ImplantableElectrodes ImplantedEuropemedicine.anatomical_structureVentricleVentricular Fibrillationcardiovascular systemCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessPacing and Clinical Electrophysiology
researchProduct

Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1

2005

Progressive supranuclear palsy (PSP) is a disorder of unknown pathogenesis. Familial clusters of PSP have been reported related to mutations of protein tau. We report the linkage of a large Spanish family with typical autosomal dominant PSP to a new locus in chromosome 1. Four members of this family had typical PSP, confirmed by neuropathology in one case. At least five ancestors had similar disease. Other members of the family have incomplete phenotypes. The power of the linkage analysis was increased by detecting presymptomatic individuals with 18F-fluoro-dopa and 18F-deoxyglucose positron emission tomography. We screened the human genome with 340 polymorphic markers and we enriched the a…

MaleGenetic LinkageTau proteinLocus (genetics)NeuropathologyProgressive supranuclear palsyGenetic linkagemedicineHumansAgedBrain ChemistryGeneticsbiologyPutamenChromosomeDNAMiddle Agedmedicine.diseaseeye diseasesDihydroxyphenylalaninePedigreeChromosome 17 (human)GlucosePhenotypeNeurologyChromosomes Human Pair 1Genetic markerPositron-Emission Tomographybiology.proteinFemaleSupranuclear Palsy ProgressiveNeurology (clinical)Caudate NucleusLod ScoreRadiopharmaceuticalsAnnals of Neurology
researchProduct

Variable phenotype in 17q12 microdeletions: Clinical and molecular characterization of a new case

2014

Microdeletions of 17q12 including the hepatocyte nuclear factor 1 beta (HNF1B) gene, as well as point mutations of this gene, are associated with the Renal Cysts and Diabetes syndrome (RCAD, OMIM 137920) and genitourinary alterations. Also, microdeletions encompassing HNF1B were identified as a cause of Mayer-Rokitansky-Kuster-Hauser Syndrome (MRKH, OMIM 277000) in females and, recently, were associated with intellectual disability, autistic features, cerebral anomaly and facial dysmorphisms. In this report, we describe a boy with a deletion in 17q12 region detected by SNP array, encompassing the HNF1B gene, that showed dysmorphic features, intellectual disability (ID), serious speech delay…

MaleLIM-Homeodomain ProteinsSingle-nucleotide polymorphismHaploinsufficiencyBiologyBioinformaticsPolymorphism Single NucleotideIntellectual DisabilityIntellectual disabilityGeneticsmedicineHumansAbnormalities MultipleLanguage Development DisordersAutistic DisorderChildHNF1B 17q12 SNP array Renal Cysts and Diabetes syndrome Intellectual disabilityHepatocyte Nuclear Factor 1-betaGeneticsHaplotypeForkhead Transcription FactorsGeneral Medicinemedicine.diseaseHNF1BPenetrancePhenotypeHaplotypesSpeech delayFemalemedicine.symptomChromosome DeletionHaploinsufficiencySNP arrayAcetyl-CoA CarboxylaseChromosomes Human Pair 17Transcription Factors
researchProduct

Trends in congenital anomalies in Europe from 1980 to 2012

2018

Background Surveillance of congenital anomalies is important to identify potential teratogens. Methods This study analysed the prevalence of 61 congenital anomaly subgroups (excluding chromosomal) in 25 population-based EUROCAT registries (1980–2012). Live births, fetal deaths and terminations of pregnancy for fetal anomaly were analysed with multilevel random-effects Poisson regression models. Results Seventeen anomaly subgroups had statistically significant trends from 2003±2012; 12 increasing and 5 decreasing. Conclusions The annual increasing prevalence of severe congenital heart defects, single ventricle, atrioventricular septal defects and tetralogy of Fallot of 1.4% (95% CI: 0.7% to …

MaleMaternal HealthLimb Reduction Defectslcsh:MedicineHEART-DEFECTS030204 cardiovascular system & hematologyFOLIC-ACID FORTIFICATIONPathology and Laboratory MedicineGeographical Locations0302 clinical medicineEUROCATPregnancyDuctus arteriosusPrevalenceMedicine and Health SciencesMorphogenesis030212 general & internal medicineRegistrieslcsh:ScienceTetralogy of FallotRISKStenosiseducation.field_of_studyMultidisciplinaryObstetricsIncidence (epidemiology)Obstetrics and GynecologyHeartASSOCIATIONCongenital Heart DefectsCongenital AnomaliesEuropePOPULATION-BASED EVALUATIONmedicine.anatomical_structurecongenital anomalies ; surveillance epidemiologyPopulation SurveillanceMicrocephalyNEURAL-TUBE DEFECTSFemaleAnatomyResearch Articlemedicine.medical_specialtyCardiac VentriclesPopulationCardiologyHistory 21st CenturyDuodenal atresiaEurope/epidemiologyCongenital Abnormalities03 medical and health sciencesSigns and SymptomsDiagnostic MedicinemedicineCongenital DisordersHumansBirth DefectseducationPregnancyZIKA VIRUS-INFECTIONbusiness.industrylcsh:RBiology and Life SciencesHistory 20th Centurymedicine.diseaseCongenital Abnormalities/diagnosisCongenital Abnormalities/diagnosis; Congenital Abnormalities/epidemiology; Congenital Abnormalities/etiology; Congenital Abnormalities/history; Europe/epidemiology; Female; History 20th Century; History 21st Century; Humans; Male; Population Surveillance; Pregnancy; Prevalence; RegistriesTeratologyREDUCTIONAtresiaPeople and PlacesBirthCardiovascular AnatomyVentricular Septal DefectsWomen's Healthlcsh:QbusinessDevelopmental BiologyPLoS One
researchProduct

Role of TGF-β Pathway Polymorphisms in Sporadic Thoracic Aortic Aneurysm: rs900 TGF-β2 Is a Marker of Differential Gender Susceptibility

2013

Thoracic aortic aneurysm (TAA) is a progressive disorder involving gradual dilation of ascending and/or descending thoracic aorta with dissection or rupture as complications. It occurs as sporadic or defined syndromes/familial forms.Genetic, molecular and cellular mechanims of sporadic TAA forms are poorly characterized and known. Thus, our interest has been focused on investigating the role of genetic variants of transforming growth factor-β(TGF-β) pathways in TAA risk. On the other hand, no data on the role of genetic variants of TGF-βpathway in sporadic TAA exist until now. In addition, other cytokines, including IL-10, orchestrate TAA pathophysiology. Their balance determines the ultima…

MalePathologyThoracicGene FrequencyProtein IsoformsThoracic aortaReceptorSingle Nucleotidesporadic TAAAdult; Aged; Aortic Aneurysm Thoracic; Female; Gene Frequency; Genotype; Humans; Interleukin-10; Male; Middle Aged; Protein Isoforms; Regression Analysis; Sex Factors; Transforming Growth Factor beta2; Genetic Predisposition to Disease; Polymorphism Single NucleotideMiddle AgedPathophysiologyAortic AneurysmInterleukin-10Interleukin 10Regression AnalysisFemaleInflammationResearch Articlelcsh:RB1-214TGF-beta SNPAdultmedicine.medical_specialtyArticle SubjectGenotypeImmunologyBiologyPolymorphism Single NucleotideThoracic aortic aneurysmcomplex mixturesTransforming Growth Factor beta2Sex Factorsmedicine.arteryparasitic diseasesmedicinelcsh:PathologyHumansSNPSettore MED/05 - Patologia ClinicaGenetic Predisposition to DiseasePolymorphismAllele frequencyAgedSettore MED/04 - Patologia GeneraleAortic Aneurysm ThoracicSettore MED/23 - Chirurgia CardiacaCell Biologymedicine.diseasedigestive system diseasesTransforming growth factorTGF-beta SNPs; sporadic TAA; InflammationMediators of Inflammation
researchProduct

Allocortical neurofibrillary changes in progressive supranuclear palsy.

1992

Silver techniques for intraneuronal cytoskeleton abnormalities (neurofibrillary tangles and neuropil threads) and extracellular A4-amyloid deposits were used to examine lesions of the cerebral cortex in six cases of progressive supranuclear palsy (three were mentally unimpaired and three showed moderate degrees of dementia). Deposits of A4-amyloid protein occurred in small numbers or were absent. Neurofibrillary tangles and neuropil threads were present in all cases and were largely confined to the allocortex. A characteristic pattern of changes was found in the entorhinal cortex. The three mentally unimpaired individuals had mild cortical changes virtually confined to the transentorhinal r…

MalePathologymedicine.medical_specialtyAmyloidSilver StainingHippocampusBiologyHippocampal formationHippocampusPathology and Forensic MedicineProgressive supranuclear palsyCellular and Molecular NeuroscienceAlzheimer DiseasemedicineHumansAgedCerebral CortexAllocortexBrainNeurofibrillary tangleNeurofibrillary TanglesMiddle AgedPerforant pathmedicine.diseaseEntorhinal cortexmedicine.anatomical_structureCerebral cortexFemaleNeurology (clinical)Supranuclear Palsy ProgressiveActa neuropathologica
researchProduct

Disease and patient characteristics in NP-C patients: findings from an international disease registry.

2013

Abstract Background Niemann-Pick disease type C (NP-C) is a rare neurovisceral disease characterized by progressive neurodegeneration and premature death. We report data recorded at enrolment in an ongoing international NP-C registry initiated in September 2009 to describe disease natural history, clinical course and treatment experience of NP-C patients in clinical practice settings. Methods The NPC Registry is a prospective observational cohort study. Participating sites are encouraged to evaluate all consecutive patients with a confirmed diagnosis of NP-C, regardless of their treatment status. All patients undergo clinical assessments and medical care as determined by their physicians. D…

MalePediatricslcsh:Medicine[SDV.GEN] Life Sciences [q-bio]/Genetics0302 clinical medicineMiglustatDiagnosisGenetics(clinical)Pharmacology (medical)Prospective StudiesRegistriesAge of OnsetEnzyme InhibitorsChildProspective cohort studyGenetics (clinical)Medicine(all)0303 health sciencesCholestasisNiemann-Pick disease type CNiemann-Pick Disease Type CGeneral MedicineDysphagia3. Good healthChild PreschoolCohortNeurologicalFemalemedicine.symptomCohort studymedicine.drugHepatomegalymedicine.medical_specialty1-DeoxynojirimycinAtaxiaAdolescent03 medical and health sciencesDisease registrymedicineHumansDisabled PersonsVertical supranuclear palsy030304 developmental biology[SDV.GEN]Life Sciences [q-bio]/Geneticsbusiness.industryResearchlcsh:RInfantMutationSymptomsSplenomegalyAge of onsetbusiness030217 neurology & neurosurgery
researchProduct

Niemann-Pick disease type C symptomatology: an expert-based clinical description

2013

Niemann-Pick disease type C (NP-C) is a rare, progressive, irreversible disease leading to disabling neurological manifestations and premature death. The estimated disease incidence is 1:120,000 live births, but this likely represents an underestimate, as the disease may be under-diagnosed due to its highly heterogeneous presentation. NP-C is characterised by visceral, neurological and psychiatric manifestations that are not specific to the disease and that can be found in other conditions. The aim of this review is to provide non-specialists with an expert-based, detailed description of NP-C signs and symptoms, including how they present in patients and how they can be assessed. Early dise…

MalePediatricsmedicine.medical_specialtyPsychosisAtaxiaReviewDiseaseGelastic cataplexyDysarthriaDiagnosisMiglustatHumansMedicineGenetics(clinical)Pharmacology (medical)Lysosomal lipid storage diseaseVertical supranuclear gaze palsyCognitive declineGenetics (clinical)DystoniaMedicine(all)Niemann–Pick disease type Cbusiness.industryNiemann-Pick disease type CNiemann-Pick Disease Type CGeneral Medicinemedicine.diseaseDystoniaCognitive impairmentSplenomegalyAtaxiaFemalemedicine.symptombusinessmedicine.drugOrphanet Journal of Rare Diseases
researchProduct